Serum prolactin response to acute and chronic cimetidine administration in man.

Acta hepato-gastroenterologica Pub Date : 1979-12-01
G Cavallini, V Lo Cascio, G Angelini, P Bovo, G Galvanini, B Vaona, L Cominacini, L A Scuro
{"title":"Serum prolactin response to acute and chronic cimetidine administration in man.","authors":"G Cavallini,&nbsp;V Lo Cascio,&nbsp;G Angelini,&nbsp;P Bovo,&nbsp;G Galvanini,&nbsp;B Vaona,&nbsp;L Cominacini,&nbsp;L A Scuro","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Unlabelled: </strong>The effects of cimetidine administration on the serum prolactin (PRL) response has been studied in twenty healthy volunteers and 46 duodenal ulcer patients. Cimetidine acute administration in two different doses (200 or 400 mg i.v.) induced a similar conspicuous rise of PRL while CB154, a dopaminergic drug, inhibited said increase. No high PRL level was observed when the drug was administered per os in a single acute dose (800 mg), nor in the chronic short-term treatment (1 g/die/28 days) for duodenal ulcer.</p><p><strong>Conclusions: </strong>1. Cimetidine has no antidopaminergic activity or this hypothetic action is very slight; 2. serum PRL increase after the drug is probably ascribable to the H2-receptor blocking, 3. this effect is observable only with the bolus i.v. of cimetidine, but not during or after acute and chronic oral administration.</p>","PeriodicalId":7089,"journal":{"name":"Acta hepato-gastroenterologica","volume":"26 6","pages":"482-5"},"PeriodicalIF":0.0000,"publicationDate":"1979-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta hepato-gastroenterologica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Unlabelled: The effects of cimetidine administration on the serum prolactin (PRL) response has been studied in twenty healthy volunteers and 46 duodenal ulcer patients. Cimetidine acute administration in two different doses (200 or 400 mg i.v.) induced a similar conspicuous rise of PRL while CB154, a dopaminergic drug, inhibited said increase. No high PRL level was observed when the drug was administered per os in a single acute dose (800 mg), nor in the chronic short-term treatment (1 g/die/28 days) for duodenal ulcer.

Conclusions: 1. Cimetidine has no antidopaminergic activity or this hypothetic action is very slight; 2. serum PRL increase after the drug is probably ascribable to the H2-receptor blocking, 3. this effect is observable only with the bolus i.v. of cimetidine, but not during or after acute and chronic oral administration.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血清催乳素对急性和慢性给药西米替丁的反应。
未标记:在20名健康志愿者和46名十二指肠溃疡患者中研究了西咪替丁给药对血清催乳素(PRL)反应的影响。两种不同剂量的西咪替丁急性给药(200mg或400mg i.v)诱导PRL相似的显著上升,而CB154,一种多巴胺能药物,抑制这种增加。在十二指肠溃疡单次急性剂量(800 mg)和慢性短期治疗(1 g/d /28天)中均未观察到PRL水平高。结论:1。西咪替丁没有抗多巴胺活性或这种假设的作用非常轻微;2. 用药后血清PRL升高可能是由于h2受体阻断所致。这种效果仅在静脉注射西咪替丁时观察到,而在急性和慢性口服给药期间或之后没有观察到。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Peroxidase activity in non-parenchymal cells isolated from rat liver: a cytochemical study. The analysis of stain loading tests for the assessment of the liver function. Parenteral nutrition. Semiquantitative determination of liver specific antigen in the urine or rats with toxic hepatic necrosis. Aortic stenosis--angiodysplasia of the caecum.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1